Authors


Megha Gandhi, PharmD Candidate

Latest:

The Impact of Community Pharmacists on Social Determinants of Health

Having community pharmacists to influence outcomes associated with social determinants of health in the US population is vital to improving overall patient outcomes.


Tiffany Davis, PharmD

Latest:

Safe Medication Practices: Prevent Diversion During Drug Disposal

Building a team to support best practices, medication safety, and staff education can reduce risks.


Elizabeth Cherry, PharmD, MMHC, CSP

Latest:

Breaking Silos: How Health Systems and Manufacturers Can Drive Progress Together

Vanderbilt Specialty Pharmacy and Takeda Oncology are reaching across silos and entering an innovative partnership to improve patient care across the entire medication journey.


Bony Mathew, PharmD Candidate

Latest:

Fourth-Year Pharmacy Students Help Patients and Practitioners in Transitional Care

Students are being exposed to new patient experiences through collaboration with practitioners.


Lindsey Sawtelle

Latest:

Osteoarthritis Management: Determine What Patients Know, Then Fill in Gaps

In patients already using analgesics for pain control, pharmacists need to address medication adherence for improved osteoarthritis symptom control.


Janet Espirito, PharmD

Latest:

ASCO 2025: Real-World Outcomes of Frontline ICI Therapy in BRAF-Mutated Melanoma in the Community Setting

Janet Espirito, PharmD, discusses real-world outcomes from a large community oncology study showing that patients with BRAF-mutated melanoma—including those with brain metastases—experienced similar benefit from frontline immune checkpoint inhibitor (ICI) therapy.


Carol Liotta-Bono, PharmD, BCPS, CDCES

Latest:

Let’s Not Forget the Silent Killer: Hypertension

The prevalence of hypertension continues to increase amongst adults in the United States, leading to other cardiovascular conditions. Lifestyle changes and medication adherence are essential for appropriate hypertension management.


Khemraj Hirani, PhD, RPh, MBA, MPharm, RAC, CIP, CCRP

Latest:

Are OTC Proton Pump Inhibitors a Boon Or a Curse?

The risk of therapy duplication with OTC and prescription PPIs can be lowered with an innovative, multi-faceted, and intentional approach by pharmacy teams and prescribers.


Katie Hosteng, PhD

Latest:

Multisite Health-Systems Specialty Pharmacy Study Evaluates Adherence to Self-Administered Biologic Disease-Modifying Antirheumatic Drugs

High adherence to treatment is a key first step toward better patient outcomes, including sustained disease control or remission.


Matthew Yeates, PharmD

Latest:

Three Strategies for Pharmacists to Maximize Their Potential as Caregivers Beyond the Bench

In recent years, pharmacist roles have evolved as critically important caregivers who increasingly provide essential health care services far beyond medication dispensing.




Stephanie Miller, PhD

Latest:

AAN 2025: AI's Promising Role in Cognitive Decline Research and Personalized Medicine

Stephanie Miller, PhD discusses how artificial intelligence can revolutionize medical research by assisting in drug development and potentially providing more targeted treatments across various diseases.


Jordan F Dow, PharmD, MS, FACHE

Latest:

Evaluation of a Chemotherapy Advanced Preparation Pilot Program to Improve Throughput in an Oncology Infusion Clinic

Pharmacy workflow changes in the preparation of chemotherapy products can reduce patient chair time.


Chris McElvany

Latest:

There Are Two Significant Advantages to the Decriminalization of Psychedelics

To build a brighter, healthier, and more equitable future for all US citizens, there is an indisputable need to decriminalize psychedelic medicines.


Yijun Cai, PharmD Candidate

Latest:

Advancing Treatment Selection in CLL Management

Treatment options are distinct in their mechanisms, safety profiles, and implications for patients’ quality of life.


Ravi Parikh, MD, MPP, FACP

Latest:

Real-World Data, Real-Time Decisions: AI at the Front Lines of Oncology

Ravi Parikh, MD, MPP, FACP, discusses how artificial intelligence is transforming oncology pharmacy by accelerating drug development, enhancing clinical decision-making, supporting value-based care, and raising critical questions about ethics, regulation, and data integrity.


Josh Lindstrom

Latest:

Telehealth & AI: Enhancing Accessibility and Continuity in Patient Care

The transformation brought about by these technologies is akin to a revolution in health care.


Allison Butts, PharmD, BCOP

Latest:

FDA Sheds Light on New Drug Approvals in Breast Cancer

The FDA is modernizing its approach to drug development and optimization.


Helen Pervanas, PharmD

Latest:

Patient Perceptions Support Co-Management of Chronic Kidney Disease

A collaborative care model enhances education and management for patients with chronic kidney disease, improving outcomes and understanding.


Luis Diestre Martin

Latest:

Illegal Online Pharmacies Are Putting Patients at Risk

The growing volume of drugs sold through illegal online pharmacies are estimated to generate 10 times higher adverse event rates than drugs sold through legal pharmacies.


Marvin Guardado

Latest:

Navigating the Great Medicare Migration: How Pharmacists Can Build Stronger Patient Relationships During the Annual Enrollment Period

The future of health care is one where pharmacists play a pivotal role, and the Annual Enrollment Period is the perfect opportunity to prove it.


Elizabeth Marino

Latest:

Case Studies: August 2022

How would you respond to these patients questions?


Rachel Shteierman, PharmD Candidate

Latest:

St. John’s Wort Could Show Benefit in Major Depressive Disorder

Patients with MDD may also seek complementary or alternative therapies in the form of dietary supplements which might be perceived by patients to be natural and safer than medicinal agents.


Casey W. Baker, JD

Latest:

Is the 340B Hospitals Battle at the Supreme Court Over?

Decision on payment reductions looks fleeting as ruling also provides HHS with instructions on cost-cutting goals.


Richard F Arndt, PharmD, BCPS

Latest:

Evaluation of a Chemotherapy Advanced Preparation Pilot Program to Improve Throughput in an Oncology Infusion Clinic

Pharmacy workflow changes in the preparation of chemotherapy products can reduce patient chair time.



Fendi Jan, PharmD

Latest:

Immune Checkpoint Inhibitors Change Treatment Landscape for Metastatic Cervical Cancer

Approval of a novel antibody-drug conjugate ushers in new second-line option.


Zainab Sabrie, MPharm, PharmD

Latest:

Novel Treatments Could Turn the Tide for Alzheimer Disease

Anti-amyloid antibody administration decreased plaque volume in clinical trials of patients with early AD, indicating that passive immunotherapies could be a promising treatment for the disease.


© 2025 MJH Life Sciences

All rights reserved.